Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.53B
Enterprise Value9.03B
P/E Ratio22.26
PEG Ratio-1.19
Price/Sales Ratio2.18
Price/Book Ratio1.57
Enterprise/Revenue2.45
Enterprise/EBITDA16.01

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.1
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.07

Income Statement

Revenue3.4B
Revenue/Share7.76
Gross Profit1.4B
EBITDA729.46M
Net Income400.51M
Diluted EPS0.88

Balance Sheet

Total Cash1.49B
Total Cash/Share3.28
Total Debt1.37B
Total Debt/Equity0.29
Current Ratio1.52
Book Value Per Share11.68

Price History

52-Week Change-19.69
52-Week High21.51
52-Week Low13.91
Moving Average 50 Days16.81
Moving Average 200 Days17.34

Statistics

Average Volume5.12M
Shares Outstanding464.75M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.4
Trailing Annual Dividend Yield2.42
Payout Ratio0.63
Last Split Factor1993579:1000000
Last Split DateApril 22, 2014
AD